Literature DB >> 14977525

Frizzled/WNT signalling: the insidious promoter of tumour growth and progression.

Elizabeth Vincan1.   

Abstract

The recognition that the processes involved in tumour formation are strikingly similar to developmental morphogenetic processes, such as gastrulation, has refashioned our approach to cancer research. Wnt and its receptor Frizzled govern the morphogenetic processes of gastrulation. Directed cell movements during gastrulation require the cells to undergo transient epithelial to mesenchymal transitions, enabling the cells to dissociate and migrate. To do this, Frizzleds activate different intracellular signalling cascades that affect cellular processes such as differentiation, proliferation, cell motility and cell polarity. Cell dissociation and migration are also essential for tumour cell invasion and metastases and the frequent deregulation of Wnt and Frizzled in human cancers implicates them in this process. Indeed recent evidence links both canonical (Wnt/beta-catenin) and non-canonical (Wnt/Ca2+) pathways to tumour invasion and metastases, emphasizing the importance of Frizzled in tumour growth and progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977525     DOI: 10.2741/1311

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Wnt/Frizzled signaling controls C. elegans gastrulation by activating actomyosin contractility.

Authors:  Jen-Yi Lee; Daniel J Marston; Timothy Walston; Jeff Hardin; Ari Halberstadt; Bob Goldstein
Journal:  Curr Biol       Date:  2006-10-24       Impact factor: 10.834

2.  Lzts2 regulates embryonic cell movements and dorsoventral patterning through interaction with and export of nuclear β-catenin in zebrafish.

Authors:  Yuanyuan Li; Qing Li; Yong Long; Zongbin Cui
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

3.  AHR regulates WT1 genetic programming during murine nephrogenesis.

Authors:  M Hadi Falahatpisheh; Adrian Nanez; Kenneth S Ramos
Journal:  Mol Med       Date:  2011-08-18       Impact factor: 6.354

4.  Nucleoporin 62-like protein activates canonical Wnt signaling through facilitating the nuclear import of β-catenin in zebrafish.

Authors:  Xiaojie Yang; Qilin Gu; Li Lin; Shaoyang Li; Shan Zhong; Qing Li; Zongbin Cui
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

5.  Frizzled7 Activates β-Catenin-Dependent and β-Catenin-Independent Wnt Signalling Pathways During Developmental Morphogenesis: Implications for Therapeutic Targeting in Colorectal Cancer.

Authors:  Bang Manh Tran; Dustin James Flanagan; Toby James Phesse; Elizabeth Vincan
Journal:  Handb Exp Pharmacol       Date:  2021

Review 6.  The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression.

Authors:  Elizabeth Vincan; Nick Barker
Journal:  Clin Exp Metastasis       Date:  2008-03-19       Impact factor: 5.150

7.  Germline Genetic Variants in the Wnt/β-Catenin Pathway as Predictors of Colorectal Cancer Risk.

Authors:  Michelle A T Hildebrandt; Monica E Reyes; Moubin Lin; Yonggang He; Son V Nguyen; Ernest T Hawk; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-25       Impact factor: 4.254

8.  Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.

Authors:  Miran Kim; Han Chu Lee; Orkhontuya Tsedensodnom; Rochelle Hartley; Young-Suk Lim; Eunsil Yu; Philippe Merle; Jack R Wands
Journal:  J Hepatol       Date:  2008-02-07       Impact factor: 25.083

9.  Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

Authors:  Mark R Morris; Eamonn R Maher
Journal:  Genome Med       Date:  2010-09-03       Impact factor: 11.117

10.  Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells.

Authors:  Karin Leandersson; Kristian Riesbeck; Tommy Andersson
Journal:  Nucleic Acids Res       Date:  2006-08-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.